Precision BioSciences Inc
NASDAQ:DTIL

Watchlist Manager
Precision BioSciences Inc Logo
Precision BioSciences Inc
NASDAQ:DTIL
Watchlist
Price: 4.86 USD 2.1% Market Closed
Market Cap: 57.3m USD

Wall Street
Price Targets

DTIL Price Targets Summary
Precision BioSciences Inc

Wall Street analysts forecast DTIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DTIL is 33.15 USD with a low forecast of 19.19 USD and a high forecast of 63 USD.

Lowest
Price Target
19.19 USD
295% Upside
Average
Price Target
33.15 USD
582% Upside
Highest
Price Target
63 USD
1 196% Upside
Precision BioSciences Inc Competitors:
Price Targets
BNTX
BioNTech SE
46% Upside
2171
CARsgen Therapeutics Holdings Ltd
33% Upside
INSM
Insmed Inc
12% Upside
GNS
Genus PLC
14% Upside
MRNA
Moderna Inc
35% Upside
COYA
Coya Therapeutics Inc
167% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
21% Upside
4593
Healios KK
56% Upside

Revenue
Forecast

Revenue Estimate
Precision BioSciences Inc

For the last 7 years the compound annual growth rate for Precision BioSciences Inc's revenue is 40%. The projected CAGR for the next 3 years is -35%.

40%
Past Growth
-35%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Precision BioSciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Precision BioSciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DTIL's stock price target?
Price Target
33.15 USD

According to Wall Street analysts, the average 1-year price target for DTIL is 33.15 USD with a low forecast of 19.19 USD and a high forecast of 63 USD.

What is Precision BioSciences Inc's Revenue forecast?
Projected CAGR
-35%

For the last 7 years the compound annual growth rate for Precision BioSciences Inc's revenue is 40%. The projected CAGR for the next 3 years is -35%.

Back to Top